A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells

@article{Kogan2006ACQ,
  title={A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells},
  author={N. M. Kogan and C. Bl{\'a}zquez and L. Alvarez and R. Gallily and M. Schlesinger and M. Guzm{\'a}n and R. Mechoulam},
  journal={Molecular Pharmacology},
  year={2006},
  volume={70},
  pages={51 - 59}
}
  • N. M. Kogan, C. Blázquez, +4 authors R. Mechoulam
  • Published 2006
  • Biology, Medicine
  • Molecular Pharmacology
  • Recent findings on the inhibition of angiogenesis and vascular endothelial cell proliferation by anthracycline antibiotics, which contain a quinone moiety, make this type of compound a very promising lead in cancer research/therapy. We have reported that a new cannabinoid anticancer quinone, cannabidiol hydroxyquinone (HU-331), is highly effective against tumor xenografts in nude mice. For evaluation of the antiangiogenic action of cannabinoid quinones, collagen-embedded rat aortic ring assay… CONTINUE READING
    HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor
    42
    Cannabinoids as Potential Antitumoral Agents in Pancreatic Cancer
    1
    Cannabinoids and Gliomas
    66

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 38 REFERENCES
    Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
    190
    Inhibition of tumor angiogenesis by cannabinoids
    245
    Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
    345
    The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.
    375
    Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
    121
    Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
    277
    Functional CB1 cannabinoid receptors in human vascular endothelial cells.
    141